Search

Author/Creator Markevärn, Berit

1. Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era – a report from the Swedish CML register. (19th August 2016)

Authors:
Söderlund, Stina; Dahlén, Torsten; Sandin, Fredrik; Olsson‐Strömberg, Ulla; Creignou, Maria; Dreimane, Arta; Lübking, Anna; Markevärn, Berit; Själander, Anders; Wadenvik, Hans; Stenke, Leif; Richter, Johan; Höglund, Martin
Journal:
European journal of haematology
Issue:
Volume 98:Number 1(2017:Jan.)
Page Start:
57
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase‐2 study (NordCML006). (13th September 2014)

Authors:
Hjorth‐Hansen, Henrik; Stenke, Leif; Söderlund, Stina; Dreimane, Arta; Ehrencrona, Hans; Gedde‐Dahl, Tobias; Gjertsen, Bjørn Tore; Höglund, Martin; Koskenvesa, Perttu; Lotfi, Kourosh; Majeed, Waleed; Markevärn, Berit; Ohm, Lotta; Olsson‐Strömberg, Ulla; Remes, Kari; Suominen, Merja; Simonsson, Be...
Journal:
European journal of haematology
Issue:
Volume 94:Number 3(2015:Mar.)
Page Start:
243
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. (2nd September 2019)

Authors:
Kreutzman, Anna; Yadav, Bhagwan; Brummendorf, Tim H.; Gjertsen, Bjorn Tore; Hee Lee, Moon; Janssen, Jeroen; Kasanen, Tiina; Koskenvesa, Perttu; Lotfi, Kourosh; Markevärn, Berit; Olsson-Strömberg, Ulla; Stentoft, Jesper; Stenke, Leif; Söderlund, Stina; Udby, Lene; Richter, Johan; Hjorth-Hansen, He...
Journal:
Oncoimmunology
Issue:
Volume 8:Number 9(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long‐term tolerability and efficacy after initial PegIFN‐α addition to dasatinib in CML‐CP: Five‐year follow‐up of the NordCML007 study. (31st August 2021)

Authors:
Flygt, Hjalmar; Söderlund, Stina; Stentoft, Jesper; Richter, Johan; Koskenvesa, Perttu; Mustjoki, Satu; Majeed, Waleed; Lübking, Anna; Dreimane, Arta; Markevärn, Berit; Stenke, Leif; Myhr Eriksson, Kristina; Gjertsen, Bjørn Tore; Gedde‐Dahl, Tobias; Dimitrijevic, Andreja; Udby, Lene; Olsson‐Ström...
Journal:
European journal of haematology
Issue:
Volume 107:Number 6(2021)
Page Start:
617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era. (27th March 2015)

Authors:
Gunnarsson, Niklas; Stenke, Leif; Höglund, Martin; Sandin, Fredrik; Björkholm, Magnus; Dreimane, Arta; Lambe, Mats; Markevärn, Berit; Olsson‐Strömberg, Ulla; Richter, Johan; Wadenvik, Hans; Wallvik, Jonas; Själander, Anders
Journal:
British journal of haematology
Issue:
Volume 169:Number 5(2015:Jun.)
Page Start:
683
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Successful tyrosine kinase inhibitor discontinuation outside clinical trials — data from the population‐based Swedish chronic myeloid leukaemia registry. (30th March 2021)

Authors:
Flygt, Hjalmar; Sandin, Fredrik; Dahlén, Torsten; Dremaine, Arta; Lübking, Anna; Markevärn, Berit; Myhr‐Eriksson, Kristina; Olsson, Karin; Olsson‐Strömberg, Ulla; Själander, Anders; Söderlund, Stina; Wennström, Lovisa; Wadenvik, Hans; Stenke, Leif; Höglund, Martin; Richter, Johan
Journal:
British journal of haematology
Issue:
Volume 193:Number 5(2021)
Page Start:
915
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗